Biogen Inc. (BIIB) vs West Pharmaceutical Services, Inc. (WST)
WST leads on 8 of 15 compared metrics, though BIIB is the cheaper stock.
A side-by-side comparison of Biogen Inc. and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 9, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
BIIB
Biogen Inc.
$198.91Healthcare
WST
West Pharmaceutical Services, Inc.
$357.66Healthcare
Total return — BIIB vs WST
growth of $100 · last 30yBIIB +5658.8%WST +5186.7%BIIB compounded faster
BIIB WST
BIIB vs WST: by the numbers
- •BIIB is the larger company ($29.37B vs $25.27B market cap).
- •BIIB trades at the lower earnings multiple (21.45 vs 47.22 P/E).
- •WST converts more revenue to profit (16.85% vs 13.92% net margin).
- •WST grew revenue faster over the past five years (6.72% vs -4.80% CAGR).
- •WST pays a dividend (0.25% yield) while BIIB does not currently pay one.
Which is better, BIIB or WST?
Metric tally: BIIB 7 · WST 8It depends on what you're optimizing for:
ValueBIIB(lower P/E)
GrowthWST(faster 5Y revenue CAGR)
QualityWST(higher ROIC)
Metrics side by side
Valuation
| Metric | BIIB | WST |
|---|---|---|
| P/E ratio | 21.45● | 47.22 |
| Forward P/E | 13.80● | 41.06 |
| P/S ratio | 3.02● | 7.95 |
| P/B ratio | 1.59● | 8.56 |
| PEG ratio | — | 33.99 |
| EV / EBITDA | 13.54● | 30.18 |
| FCF yield | 8.83%● | 1.79% |
Profitability
| Metric | BIIB | WST |
|---|---|---|
| Gross margin | 69.77%● | 36.24% |
| Operating margin | 15.65% | 20.67%● |
| Net margin | 13.92% | 16.85%● |
| ROE | 7.36% | 18.15%● |
| ROIC | 6.62% | 13.62%● |
Dividends
| Metric | BIIB | WST |
|---|---|---|
| Dividend yield | — | 0.25% |
| Payout ratio | — | 12.88% |
Growth (annualized)
| Metric | BIIB | WST |
|---|---|---|
| Revenue CAGR (5Y) | -4.80% | 6.72%● |
| EPS CAGR (5Y) | -18.67% | 7.85%● |
| FCF CAGR (5Y) | -3.59% | 8.32%● |
| Total return CAGR (5Y) | -11.50% | -0.81%● |
Frequently asked
- Which is better, BIIB or WST?
- It depends on your goal. value: BIIB (lower P/E); growth: WST (faster 5Y revenue CAGR); quality: WST (higher ROIC). Across all compared metrics, WST leads 8 to 7.
- Is BIIB or WST cheaper?
- On trailing earnings, BIIB is cheaper: BIIB trades at a 21.45 P/E and WST at 47.22.
- Which has grown faster, BIIB or WST?
- Over the past five years, WST grew revenue faster — BIIB at a -4.80% CAGR versus WST at 6.72%.
- Does BIIB or WST pay a bigger dividend?
- WST pays a dividend (0.25% yield) while BIIB does not currently pay one.
- Is BIIB or WST more profitable?
- WST runs the higher net margin — BIIB at 13.92% versus WST at 16.85%.
- Which has been the better investment, BIIB or WST?
- Over the past 10-year, WST delivered the higher annualized total return — BIIB at -2.24% versus WST at 16.87%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioWest Pharmaceutical Services P/E ratioBiogen dividend yieldWest Pharmaceutical Services dividend yieldBiogen ROEWest Pharmaceutical Services ROEBiogen operating marginWest Pharmaceutical Services operating marginBiogen revenue growthWest Pharmaceutical Services revenue growthBiogen free cash flowWest Pharmaceutical Services free cash flow
Biogen & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 9, 2026.